Literature DB >> 18021929

Pallidal stimulation for dystonia in pantothenate kinase-associated neurodegeneration.

Donald C Shields1, Nutan Sharma, John T Gale, Emad N Eskandar.   

Abstract

Patients with generalized dystonia secondary to pantothenate kinase-associated neurodegeneration are traditionally treated palliatively with medical therapy. Therapeutic advances include stereotactic basal ganglia ablative techniques and, more recently, pallidal deep-brain stimulation. We report the course of dystonia in a teenage male. Bilateral microelectrode-guided pallidal deep-brain stimulators were placed while the patient was awake. Three parasagittal microelectrodes were inserted simultaneously. Two anterior microelectrodes were relatively quiet. The posterior electrode demonstrated a pattern of frequent bursts with high-frequency activity. The stimulator was therefore placed in the posterior location, which resulted in symptomatic improvement. Pallidal deep-brain stimulation appears to create a functional correction that may alter globus pallidus internus inhibitory output to the motor thalamus. The prominent, noisy bursting patterns observed in the globus pallidus internus suggests that high-frequency stimulation may improve signs of dystonia by normalizing thalamic discharge patterns.

Entities:  

Mesh:

Year:  2007        PMID: 18021929     DOI: 10.1016/j.pediatrneurol.2007.08.006

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  8 in total

Review 1.  Pantothenate kinase-associated neurodegeneration (PKAN) and PLA2G6-associated neurodegeneration (PLAN): review of two major neurodegeneration with brain iron accumulation (NBIA) phenotypes.

Authors:  Manju A Kurian; Susan J Hayflick
Journal:  Int Rev Neurobiol       Date:  2013       Impact factor: 3.230

2.  Dystonia in neurodegeneration with brain iron accumulation: outcome of bilateral pallidal stimulation.

Authors:  L Timmermann; K A M Pauls; K Wieland; R Jech; G Kurlemann; N Sharma; S S Gill; C A Haenggeli; S J Hayflick; P Hogarth; K L Leenders; P Limousin; C J Malanga; E Moro; J L Ostrem; F J Revilla; P Santens; A Schnitzler; S Tisch; F Valldeoriola; J Vesper; J Volkmann; D Woitalla; S Peker
Journal:  Brain       Date:  2010-03-05       Impact factor: 13.501

3.  Clinical course of patients with pantothenate kinase-associated neurodegeneration (PKAN) before and after DBS surgery.

Authors:  Marina Svetel; Aleksandra Tomić; Nataša Dragašević; Igor Petrović; Nikola Kresojević; Robert Jech; Dušan Urgošik; Isidora Banjac; Jelena Vitković; Ivana Novaković; Vladimir S Kostić
Journal:  J Neurol       Date:  2019-08-29       Impact factor: 4.849

4.  Deep brain stimulation improves quality of life in pantothenate kinase-associated neurodegeneration.

Authors:  Kiran P Sathe; Anaita U Hegde; Paresh K Doshi
Journal:  J Pediatr Neurosci       Date:  2013-01

5.  Novel compound heterozygous mutations in the pantothenate kinase 2 gene in a korean patient with atypical pantothenate kinase associated neurodegeneration.

Authors:  Sung-Hyouk Kim; Young-Hee Sung; Kee-Hyung Park; Yeung-Bae Lee; Hyeon-Mi Park; Dong Jin Shin; Gu-Hwan Kim
Journal:  J Mov Disord       Date:  2009-04-30

Review 6.  A Proposed Diagnostic Algorithm for Inborn Errors of Metabolism Presenting With Movements Disorders.

Authors:  Juan Darío Ortigoza-Escobar
Journal:  Front Neurol       Date:  2020-11-13       Impact factor: 4.003

Review 7.  Surgical Outcomes in Rare Movement Disorders: A Report of Seventeen Patients from India and Review of Literature.

Authors:  Debjyoti Dhar; Vikram Venkappayya Holla; Nitish Kamble; Ravi Yadav; Dwarakanath Srinivas; Pramod Kumar Pal
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2022-06-20

8.  Genetics and Pathophysiology of Neurodegeneration with Brain Iron Accumulation (NBIA).

Authors:  Susanne A Schneider; Petr Dusek; John Hardy; Ana Westenberger; Joseph Jankovic; Kailash P Bhatia
Journal:  Curr Neuropharmacol       Date:  2013-01       Impact factor: 7.363

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.